This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Pfizer Corporation. Active years: 2011-2020.
Company Filing History:
Years Active: 2011-2020
Title: Brian Patrick Chekal: Innovator in Pharmaceutical Chemistry
Introduction
Brian Patrick Chekal is a notable inventor based in Niantic, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating cell proliferative diseases, such as cancer. With a total of 3 patents to his name, Chekal's work exemplifies innovation in drug formulation and therapeutic applications.
Latest Patents
One of Chekal's latest patents is focused on solid forms of a selective CDK4/6 inhibitor. This invention relates to the crystalline free base of acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which possesses improved properties. The patent also covers pharmaceutical compositions and dosage forms that include this free base, along with methods for their use in treating various cell proliferative diseases, including cancer.
Another significant patent involves crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole. This invention pertains to both crystalline polymorphic and amorphous forms of the compound, as well as methods for their preparation. The patent also emphasizes the therapeutic and prophylactic uses of these polymorphic forms and the pharmaceutical compositions that contain them.
Career Highlights
Throughout his career, Brian Patrick Chekal has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Pfizer Products Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation.
Collaborations
Chekal has collaborated with notable colleagues such as Gopi Yalamanchili and George H Klemm. These partnerships have further enhanced his innovative work in the field of pharmaceutical chemistry.
Conclusion
Brian Patrick Chekal's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of drug development and a dedication to improving treatment options for serious diseases.